Treatment of patients with irritable bowel syndrome.
Weinstock
Leonard B
LB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007421:Intestine, Small / Q000382:microbiology; D043183:Irritable Bowel Syndrome / Q000188:drug therapy* / Q000382:microbiology; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin
D000900:Anti-Bacterial Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin